Minerva

Minerva

BMJ 1994; 308 doi: http://dx.doi.org/10.1136/bmj.308.6929.668 (Published 05 March 1994) Cite this as: BMJ 1994;308:668

The prospects for patients with newly diagnosed multiple myeloma have hardly changed since the mid-1960s (New England Journal of Medicine 1994;330:484-9). Treated with intermittent courses of melphalan and prednisone, about half survive three years and fewer than 10% live longer than 10 years. Newer drug regimens may induce remission more quickly but do not prolong survival. A very few patients have apparently been cured after myeloablation and bone marrow transplantation.

The Commons vote on 21 February setting 18 as the new age of consent for homosexual acts between men shows that gays have not yet been given equal rights before the law. A recent study of 623 gay men, reported in the “British Journal of General Practice” (1994;44:80-2), found that 44% had not told their doctors of their sexual orientation. Two thirds of the men had had an HIV antibody test, but only 141 of the 400 who knew their HIV status had told their doctors the result of the test.

Taxol, the cytotoxic drug extracted from the bark of the Pacific yew, Taxus brevifola, has been …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe